Novel Doxorubicin / Folate-Targeted Trans-Ferulic Acid-Loaded doxorubicin/folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.